The latest announcement is out from Amedisys ( (AMED) ).
Amedisys, Inc. reported its financial results for the fourth quarter and year ending December 31, 2024, revealing a net service revenue increase to $598.1 million for the quarter and $2,348.3 million for the year. Despite a net loss of $20.4 million for the quarter due to merger-related expenses and impairment charges, the company achieved a net income of $43.2 million for the year. Adjusted EBITDA slightly decreased, while adjusted net income per diluted share saw a marginal increase. The company announced it would not hold a quarterly earnings call due to its pending merger with UnitedHealth Group, which may impact its operations and industry positioning.
More about Amedisys
Amedisys, Inc. is a leading healthcare services company specializing in personalized home health, hospice, and high acuity care services delivered in the home. Founded in 1982 and headquartered in Baton Rouge, Louisiana, with an executive office in Nashville, Tennessee, Amedisys partners with over 3,300 hospitals and 114,000 physicians nationwide to provide post-acute care. The company operates approximately 519 care centers across 38 states and the District of Columbia, employing around 19,000 people to serve over 499,000 patients annually.
YTD Price Performance: 0.70%
Average Trading Volume: 465,287
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $3B
Find detailed analytics on AMED stock on TipRanks’ Stock Analysis page.